Further Discussion on Plasmids to Establish Release Specifications Using a Risk-Based Approach to Manage Supply
A panel of experts from bio/pharmaceutical companies discuss plasmids to establish specifications using a risk-based approach to manage supply, including the response to cell & gene therapy industry feedback, future outlook and re-evaluating plasmid risks.
